2025 SOT Annual Meeting and ToxExpo

Trailhead Biosystems Booth #523

March 16-20, 2025
Orange County Convention Center
Orlando, FL USA

Booth LocationConference Details
SOT IMAGE
SOT_team_2025 v2

Meet the team!

Stop by booth 523 to meet our team of scientific professionals and learn how Trailhead Biosystems is trailblazing with our HD-DoE® platform to create iPSC-derived cells for toxicity testing, drug discovery and disease modeling.

Explore Elevate's capabilities

We have all the tools you need to run an effective marketing strategy

Content creation

Write a brief description of the product's capabilities

Analytics and reporting

Write a brief description of the product's capabilities

Messaging

Write a brief description of the product's capabilities

Integrations

Write a brief description of the product's capabilities

Automation and workflows

Write a brief description of the product's capabilities

Campaign scheduling

Write a brief description of the product's capabilities

AI Agents

Write a brief description of the product's capabilities

Cross channel distribution

Write a brief description of the product's capabilities

VLMC_Icon

TrailBio® Vascular
Leptomeningeal Cells

Our TrailBio® Vascular Leptomeningeal Cells (VLMCs) are iPSC-derived fibroblast-like cells that form a critical component of the blood-brain barrier. Developed using our proprietary HD-DoE® platform, these neuroectoderm-derived cells line blood vessels in the subarachnoid space alongside pericytes, expressing specific markers that confirm their unique identity and function—ideal for blood-brain barrier interface studies.

More about our latest product release

Our Current Portfolio

Launched

TrailBio® Pre-Myelinating Oligodendrocytes Kit

See more

Launched

TrailBio® Vascular Leptomeningeal Cells

See more

Upcoming Launch

TrailBio® A9 Dopaminergic Neurons

See more